Opko Net Debt from 2010 to 2026

OPK Stock

USD 1.24 0.03 2.48%

Opko Health Net Debt yearly trend continues to be quite stable with very little volatility. Net Debt may rise above about 87.6 M this year. Net Debt is the total debt of Opko Health minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

1996-03-31

Previous Quarter

124 M

Current Value

-19.8 M

Quarterly Volatility

92.9 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check Opko Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Opko Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 118.5 M, Interest Expense of 57.3 M or Total Revenue of 435.2 M, as well as many indicators such as Price To Sales Ratio of 1.56, Dividend Yield of 0.0011 or PTB Ratio of 0.82. Opko financial statements analysis is a perfect complement when working with Opko Health Valuation or Volatility modules.

Build AI portfolio with Opko Stock

Check out the analysis of Opko Health Correlation against competitors.

For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Historical Net Debt data for Opko Health serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Opko Health represents a compelling investment opportunity.

Latest Opko Health's Net Debt Growth Pattern

Below is the plot of the Net Debt of Opko Health over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Opko Health's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Opko Health's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Opko Net Debt Regression Statistics

	Arithmetic Mean	48,866,448
	Geometric Mean	67,051,034
	Coefficient Of Variation	221.46
	Mean Deviation	84,863,010
	Median	66,491,000
	Standard Deviation	108,218,650
	Sample Variance	11711.3T
	Range	374.9M
	R-Value	0.59
	Mean Square Error	8088.5T
	R-Squared	0.35
	Significance	0.01
	Slope	12,723,742
	Total Sum of Squares	187380.4T

Opko Net Debt History

	2026	87.6 M
	2025	83.4 M
	2024	72.5 M
	2023	230.7 M
	2022	152.4 M
	2021	120 M
	2020	222.4 M

Other Fundumenentals of Opko Health

Net Debt To E B I T D A

Opko Health Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Debt	Short Term Investments	Net Receivables	Good Will	Net Tangible Assets	Capital Surpluse	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.18	-0.67	0.79	0.95	0.77	0.87	0.51	0.83	0.67	0.91	0.71	0.58	-0.53	0.84	0.94	0.32	0.91	0.6	0.37	0.43	-0.29	0.38	0.4
Total Stockholder Equity	0.99		0.12	-0.6	0.81	0.89	0.7	0.9	0.51	0.78	0.67	0.9	0.74	0.46	-0.51	0.86	0.96	0.23	0.89	0.52	0.38	0.37	-0.26	0.28	0.32
Net Debt	0.18	0.12		-0.67	0.43	0.29	0.28	0.01	0.57	0.52	0.37	0.36	-0.34	0.48	-0.13	0.21	0.18	0.68	0.42	-0.07	0.36	0.77	-0.38	0.37	0.69
Retained Earnings	-0.67	-0.6	-0.67		-0.62	-0.76	-0.73	-0.39	-0.8	-0.93	-0.63	-0.76	-0.27	-0.81	0.45	-0.54	-0.63	-0.83	-0.85	-0.47	-0.56	-0.87	0.45	-0.67	-0.86
Accounts Payable	0.79	0.81	0.43	-0.62		0.68	0.57	0.73	0.64	0.68	0.64	0.86	0.46	0.27	-0.39	0.92	0.87	0.35	0.85	0.1	0.4	0.62	-0.34	0.21	0.39
Total Liab	0.95	0.89	0.29	-0.76	0.68		0.86	0.72	0.49	0.88	0.61	0.86	0.56	0.79	-0.52	0.73	0.82	0.47	0.88	0.73	0.32	0.53	-0.34	0.58	0.54
Total Current Assets	0.77	0.7	0.28	-0.73	0.57	0.86		0.4	0.41	0.8	0.53	0.71	0.31	0.77	-0.4	0.71	0.59	0.65	0.75	0.64	0.22	0.57	-0.67	0.86	0.62
Intangible Assets	0.87	0.9	0.01	-0.39	0.73	0.72	0.4		0.42	0.57	0.52	0.73	0.74	0.23	-0.49	0.72	0.91	-0.09	0.77	0.33	0.28	0.23	0.0	-0.07	0.06
Short Term Debt	0.51	0.51	0.57	-0.8	0.64	0.49	0.41	0.42		0.75	0.47	0.62	0.3	0.43	-0.45	0.5	0.6	0.58	0.73	0.13	0.84	0.78	-0.25	0.28	0.67
Common Stock	0.83	0.78	0.52	-0.93	0.68	0.88	0.8	0.57	0.75		0.55	0.83	0.42	0.78	-0.65	0.64	0.75	0.7	0.88	0.56	0.52	0.72	-0.44	0.61	0.78
Treasury Stock	0.67	0.67	0.37	-0.63	0.64	0.61	0.53	0.52	0.47	0.55		0.75	0.45	0.44	0.13	0.65	0.7	0.46	0.77	0.31	0.44	0.55	-0.31	0.36	0.47
Property Plant Equipment	0.91	0.9	0.36	-0.76	0.86	0.86	0.71	0.73	0.62	0.83	0.75		0.6	0.57	-0.42	0.86	0.93	0.49	0.92	0.46	0.47	0.62	-0.28	0.39	0.51
Current Deferred Revenue	0.71	0.74	-0.34	-0.27	0.46	0.56	0.31	0.74	0.3	0.42	0.45	0.6		0.17	-0.3	0.53	0.77	-0.06	0.59	0.56	0.33	-0.01	0.24	-0.06	0.06
Long Term Debt	0.58	0.46	0.48	-0.81	0.27	0.79	0.77	0.23	0.43	0.78	0.44	0.57	0.17		-0.33	0.29	0.4	0.74	0.63	0.77	0.28	0.65	-0.35	0.8	0.77
Short Term Investments	-0.53	-0.51	-0.13	0.45	-0.39	-0.52	-0.4	-0.49	-0.45	-0.65	0.13	-0.42	-0.3	-0.33		-0.38	-0.47	-0.13	-0.46	-0.32	-0.19	-0.24	0.14	-0.17	-0.21
Net Receivables	0.84	0.86	0.21	-0.54	0.92	0.73	0.71	0.72	0.5	0.64	0.65	0.86	0.53	0.29	-0.38		0.87	0.31	0.83	0.24	0.31	0.48	-0.38	0.31	0.28
Good Will	0.94	0.96	0.18	-0.63	0.87	0.82	0.59	0.91	0.6	0.75	0.7	0.93	0.77	0.4	-0.47	0.87		0.24	0.92	0.42	0.43	0.47	-0.13	0.16	0.33
Net Tangible Assets	0.32	0.23	0.68	-0.83	0.35	0.47	0.65	-0.09	0.58	0.7	0.46	0.49	-0.06	0.74	-0.13	0.31	0.24		0.54	0.34	0.4	0.82	-0.52	0.79	0.95
Capital Surpluse	0.91	0.89	0.42	-0.85	0.85	0.88	0.75	0.77	0.73	0.88	0.77	0.92	0.59	0.63	-0.46	0.83	0.92	0.54		0.48	0.5	0.73	-0.36	0.46	0.61
Long Term Investments	0.6	0.52	-0.07	-0.47	0.1	0.73	0.64	0.33	0.13	0.56	0.31	0.46	0.56	0.77	-0.32	0.24	0.42	0.34	0.48		0.1	0.16	-0.01	0.56	0.4
Short Long Term Debt	0.37	0.38	0.36	-0.56	0.4	0.32	0.22	0.28	0.84	0.52	0.44	0.47	0.33	0.28	-0.19	0.31	0.43	0.4	0.5	0.1		0.47	-0.1	0.13	0.49
Long Term Debt Total	0.43	0.37	0.77	-0.87	0.62	0.53	0.57	0.23	0.78	0.72	0.55	0.62	-0.01	0.65	-0.24	0.48	0.47	0.82	0.73	0.16	0.47		-0.48	0.6	0.82
Net Invested Capital	-0.29	-0.26	-0.38	0.45	-0.34	-0.34	-0.67	0.0	-0.25	-0.44	-0.31	-0.28	0.24	-0.35	0.14	-0.38	-0.13	-0.52	-0.36	-0.01	-0.1	-0.48		-0.72	-0.47
Net Working Capital	0.38	0.28	0.37	-0.67	0.21	0.58	0.86	-0.07	0.28	0.61	0.36	0.39	-0.06	0.8	-0.17	0.31	0.16	0.79	0.46	0.56	0.13	0.6	-0.72		0.72
Capital Stock	0.4	0.32	0.69	-0.86	0.39	0.54	0.62	0.06	0.67	0.78	0.47	0.51	0.06	0.77	-0.21	0.28	0.33	0.95	0.61	0.4	0.49	0.82	-0.47	0.72

Click cells to compare fundamentals

About Opko Health Financial Statements

Opko Health investors utilize fundamental indicators, such as Net Debt, to predict how Opko Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	83.4 M	87.6 M
Net Debt To EBITDA	0.62	0.59

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:

How To Invest In Opko

Details

Is Opko Stock a good investment?

Details

What is Opko Health's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Opko Health Correlation against competitors.

For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. Anticipated expansion of Opko directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Opko Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.

Quarterly Earnings Growth

(0.13)

Earnings Share

(0.24)

Revenue Per Share

0.881

Return On Assets

(0.06)

Return On Equity

(0.13)

The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

It's important to distinguish between Opko Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Opko Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Opko Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Opko Net Debt from 2010 to 2026

Latest Opko Health's Net Debt Growth Pattern

Opko Net Debt Regression Statistics

Opko Net Debt History

Other Fundumenentals of Opko Health

Opko Health Net Debt component correlations

About Opko Health Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY